Yi‐wei Li
#163,172
Most Influential Person Now
Yi‐wei Li's AcademicInfluence.com Rankings
Yi‐wei Libiology Degrees
Biology
#13050
World Rank
#16574
Historical Rank
Molecular Biology
#2159
World Rank
#2193
Historical Rank
Biochemistry
#2253
World Rank
#2400
Historical Rank
Download Badge
Biology
Why Is Yi‐wei Li Influential?
(Suggest an Edit or Addition)Yi‐wei Li's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. (2009) (654)
- Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. (2009) (597)
- Multi-targeted therapy of cancer by genistein. (2008) (570)
- miR-146a suppresses invasion of pancreatic cancer cells. (2010) (428)
- Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells (2010) (402)
- Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. (2005) (383)
- Soy Isoflavones and Cancer Prevention (2003) (354)
- Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. (2006) (332)
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells (2011) (328)
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. (2010) (323)
- Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? (2011) (320)
- Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells (2006) (318)
- Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein (2004) (316)
- Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein (1999) (316)
- Pancreatic cancer: understanding and overcoming chemoresistance (2011) (315)
- Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells (2001) (314)
- miR‐200 Regulates PDGF‐D‐Mediated Epithelial–Mesenchymal Transition, Adhesion, and Invasion of Prostate Cancer Cells (2009) (310)
- Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. (2011) (296)
- The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. (2010) (283)
- Inhibition of Nuclear Factor κB Activation in PC3 Cells by Genistein Is Mediated via Akt Signaling Pathway (2002) (276)
- Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. (2012) (274)
- Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. (2007) (253)
- Using chemopreventive agents to enhance the efficacy of cancer therapy. (2006) (245)
- Cellular signaling perturbation by natural products. (2009) (232)
- Emerging role of Notch in stem cells and cancer. (2009) (229)
- NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases (2008) (225)
- Down‐regulation of Notch‐1 and Jagged‐1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF‐κB signaling pathways (2010) (220)
- Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. (2010) (217)
- Implication of microRNAs in drug resistance for designing novel cancer therapy. (2010) (211)
- Over‐expression of FoxM1 leads to epithelial–mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells (2011) (208)
- Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. (2007) (207)
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM (2012) (206)
- Retracted: Notch‐1 down‐regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells (2006) (205)
- Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research (2010) (200)
- Cell signaling pathways altered by natural chemopreventive agents. (2004) (182)
- Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells (2003) (175)
- Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. (2002) (171)
- Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment (2012) (163)
- Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. (2013) (159)
- The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. (2012) (159)
- Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy. (2013) (155)
- Forkhead box M1 transcription factor: a novel target for cancer therapy. (2010) (151)
- Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells (2008) (149)
- Indole-3-carbinol and prostate cancer. (2004) (141)
- Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. (2002) (140)
- Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells (2012) (136)
- The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. (2006) (135)
- Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs (2013) (132)
- Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. (2007) (130)
- Apoptosis-Inducing Effect of Chemotherapeutic Agents Is Potentiated by Soy Isoflavone Genistein, a Natural Inhibitor of NF-κB in BxPC-3 Pancreatic Cancer Cell Line (2004) (128)
- Cross-talk between miRNA and Notch signaling pathways in tumor development and progression. (2010) (127)
- The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer (2010) (125)
- Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. (2009) (125)
- Pancreatic cancer stem cells: emerging target for designing novel therapy. (2013) (124)
- NF-kappaB: a potential target for cancer chemoprevention and therapy. (2008) (122)
- Pancreatic cancer: pathogenesis, prevention and treatment. (2007) (122)
- Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. (2007) (121)
- Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. (2006) (121)
- RETRACTED ARTICLE: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors (2010) (120)
- Gene expression profiles of genistein-treated PC3 prostate cancer cells. (2002) (119)
- Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. (2006) (119)
- Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. (2004) (115)
- KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne? (2020) (115)
- Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. (2006) (115)
- Exploitation of the Notch signaling pathway as a novel target for cancer therapy. (2008) (114)
- Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF (2012) (114)
- Retracted: Inhibition of nuclear factor κb activity by genistein is mediated via Notch‐1 signaling pathway in pancreatic cancer cells (2006) (111)
- Regulation of FOXO3a/β-Catenin/GSK-3β Signaling by 3,3′-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer Cells* (2007) (111)
- Regulation of Akt/FOXO3a/GSK-3β/AR Signaling Network by Isoflavone in Prostate Cancer Cells* (2008) (111)
- Emerging roles of PDGF-D signaling pathway in tumor development and progression. (2010) (109)
- The role of isoflavones in cancer chemoprevention. (2004) (107)
- Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression. (2010) (107)
- Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. (2003) (105)
- Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion (2012) (101)
- Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes (2015) (99)
- Inactivation of Akt and NF-κB Play Important Roles During Indole-3-Carbinol-Induced Apoptosis in Breast Cancer Cells (2004) (98)
- The complexities of obesity and diabetes with the development and progression of pancreatic cancer. (2011) (98)
- Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. (2010) (97)
- Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells. (2008) (97)
- Down‐regulation of Notch‐1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells (2011) (96)
- Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. (2012) (96)
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells (2012) (94)
- Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. (2003) (88)
- Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. (2005) (88)
- Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. (2012) (86)
- Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. (2011) (83)
- Retracted: Cisplatin‐induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC‐3 pancreatic tumor xenografts (2006) (82)
- MicroRNA and Cancer: Tiny Molecules with Major Implications (2008) (82)
- Targeting the Hedgehog signaling pathway for cancer therapy (2012) (75)
- Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. (2007) (72)
- MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer (2016) (71)
- Regulating miRNA by natural agents as a new strategy for cancer treatment. (2013) (70)
- Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy (2007) (70)
- Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. (2006) (69)
- Notch signaling proteins: legitimate targets for cancer therapy. (2010) (69)
- Retracted: Down‐regulation of Jagged‐1 induces cell growth inhibition and S phase arrest in prostate cancer cells (2006) (65)
- PDGF-D signaling: a novel target in cancer therapy. (2009) (63)
- Synergistic effects of multiple natural products in pancreatic cancer cells. (2008) (62)
- FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer (2010) (59)
- Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling. (2012) (59)
- Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. (2006) (54)
- Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray. (2004) (54)
- Pancreatic Cancer Stem-like Cells Display Aggressive Behavior Mediated via Activation of FoxQ1 (2014) (52)
- Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness. (2013) (51)
- Targeting CSC-related miRNAs for cancer therapy by natural agents. (2012) (50)
- Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas (1992) (50)
- Induction of Cancer Cell Death by Isoflavone: The Role of Multiple Signaling Pathways (2011) (49)
- Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. (2003) (49)
- Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype (2013) (48)
- Relationship of p21WAF1 expression with disease‐free survival and biochemical recurrence in prostate adenocarcinomas (PCa) (1999) (47)
- Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis (2012) (47)
- Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? (2013) (46)
- Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-κB Signaling Pathways (2011) (45)
- Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells (2011) (45)
- Novel targets for prostate cancer chemoprevention. (2010) (44)
- Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells (2005) (43)
- Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells (2012) (42)
- Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells (2005) (41)
- The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome (2015) (41)
- Maspin augments proteasome inhibitor‐induced apoptosis in prostate cancer cells (2007) (39)
- The biological complexity of RKIP signaling in human cancers (2015) (37)
- Cell Cycle‐Dependent Effects of 3,3′‐Diindolylmethane on Proliferation and Apoptosis of Prostate Cancer Cells (2009) (37)
- Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. (2014) (37)
- Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment. (2013) (36)
- Differentially expressed miRNAs in cancer-stem-like cells: markers for tumor cell aggressiveness of pancreatic cancer. (2014) (34)
- Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line (2006) (31)
- Perspectives on the Role of Isoflavones in Prostate Cancer (2013) (31)
- Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27kip1, p57kip2, and PUMA (2013) (30)
- Induction of apoptosis in breast cancer cells by TPA (1998) (30)
- Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine (2015) (28)
- The immunological contribution of NF-κB within the tumor microenvironment: a potential protective role of zinc as an anti-tumor agent. (2012) (28)
- Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells. (2010) (26)
- Recent progress on nutraceutical research in prostate cancer (2014) (24)
- Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1 (2003) (24)
- Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors (2016) (24)
- Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation (2019) (22)
- Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration. (2017) (22)
- Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line. (2006) (21)
- The Biological Significance of Zinc in Inflammation and Aging (2014) (20)
- The bounty of nature for changing the cancer landscape. (2016) (20)
- Quantitative Chemiluminescent Immunoassay for NF‐κB–DNA Binding Activity (2005) (20)
- Direct comparison of microarray gene expression profiles between non-amplification and a modified cDNA amplification procedure applicable for needle biopsy tissues. (2003) (20)
- Role of BioResponse 3,3′-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience (2015) (19)
- Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration (2017) (17)
- Molecular Analysis of the p53 Gene in Pancreatic Adenocarcinoma (1998) (16)
- Crosstalk between miRNA and Notch signaling pathways in tumor development and progression (2010) (16)
- [The expression of bcl-2 and bax genes during microcystin induced liver tumorigenesis]. (2002) (15)
- Markers of apoptosis. (2006) (15)
- Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of notch and NF-κB signaling pathways (PLoS ONE (2011) 6, 6, (e20537) DOI: 10.1371/journal.pone.0020537) (2014) (15)
- Targeting MicroRNAs for Personalized Cancer Therapy (2013) (12)
- Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study (2021) (10)
- Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs (2021) (10)
- DNA-Methylation-Caused Downregulation of miR-30 Contributes to the High Expression of XPO1 and the Aggressive Growth of Tumors in Pancreatic Ductal Adenocarcinoma (2019) (8)
- Inactivation of AR / TMPRSS 2-ERG / Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells (2011) (7)
- Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells. (2004) (7)
- Targeting Epigenetically Deregulated miRNA by Nutraceuticals: Focusing on Cancer Prevention and Treatment (2015) (6)
- The complexities of obesity , diabetes , and the development and progression of pancreatic cancer (2011) (6)
- Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies (2012) (6)
- Stem Cells and Cancer (2016) (5)
- Activated Kras and INK 4 a / Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NFk B Signaling Pathways (2011) (5)
- Quantitative chemiluminescent immunoassay for NF-kappaB-DNA binding activity. (2005) (5)
- Cancer Therapy Using Chemopreventive Agents to Enhance the Efficacy of Updated (2006) (5)
- Plant-derived antioxidants (2006) (5)
- PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus (2021) (5)
- Targeting Cancer Stem Cells for Overcoming Drug Resistance and Cancer Progression (2014) (4)
- Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers (2022) (4)
- Inhibition of Angiogenesis and Invasion by 3 , 3 ¶-Diindolylmethane Is Mediated by the NFK B Downstream Target Genes MMP-9 and uPA that Regulated Bioavailability of VEGF in Prostate Cancer (2007) (4)
- MicroRNA Targeted Therapy for Overcoming Drug Resistance, Reversal of EMT and Elimination of Cancer Stem Cells in Prostate and Pancreatic Cancer (2014) (3)
- Nutritional Genomics in Cancer Processes Bax Translocation to Mitochondria Is an Important Event in Inducing Apoptotic Cell Death by Indole-3-Carbinol ( I 3 C ) Treatment of Breast Cancer Cells 1 (2003) (3)
- PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma (2021) (3)
- Isoflavones, Soybean Phytoestrogens, and Cancer (2005) (3)
- Abstract 1358: p21 activated kinase 4 (pak4) as a novel therapeutic target for non-hodgkin's lymphoma (2017) (3)
- Nutrient-Gene Interactions Gene Expression Profiles of I 3 Cand DIM-Treated PC 3 Human Prostate Cancer Cells Determined by cDNA Microarray Analysis 1 (2003) (3)
- Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase 1b Study (2020) (2)
- Resistance and DNA Repair Mechanisms of Cancer Stem Cells: Potential Molecular Targets for Therapy (2013) (2)
- Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells (2021) (2)
- miRNA Targeted Therapy in Lung Cancer (2014) (2)
- miRNAs in Cancer Stem Cells (2015) (2)
- FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. (2023) (2)
- The Biological Roles of MicroRNAs in Cancer Stem Cells (2014) (1)
- Clinicopathologic significance of structural alterations of p53 protein in papillary thyroid carcinoma. (2002) (1)
- Nutrient-Gene Interactions Gene Expression Profiles of Genistein-Treated PC 3 Prostate Cancer Cells 1 (2002) (1)
- Preclinical Development Garcinol Regulates EMT andWnt Signaling Pathways In Vitro and In Vivo , Leading to Anticancer Activity against Breast Cancer Cells (2012) (1)
- Chemotherapeutic Agents in Human Cancer Cells Genistein Contributes to Increased Apoptosis Induced by B by Soy Isoflavone κ Inactivation of Nuclear Factor Updated (2005) (1)
- Abstract B66: Targeting bone remodeling by isoflavone and 3,3′-diindolylmethane in the context of prostate cancer bone metastasis (2012) (1)
- Targeting MicroRNAs: Molecular Basis of Cancer Prevention (2016) (1)
- Metastatic brain tumor models and drug brain penetration analysis (2019) (1)
- Perspectives on the Role of Iso fl avones in Prostate Cancer (2013) (1)
- The Biology of the Deadly Love Connection Between Obesity, Diabetes, and Breast Cancer (2013) (1)
- Deregulated transcription factors and poor clinical outcomes in cancer patients. (2022) (1)
- Augmenting the Efficacy of Chemo- and Radio-Therapy by Nutraceuticals: Evidence from Pre-clinical and Clinical Trials (2012) (1)
- Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy (2022) (1)
- Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells". (2018) (1)
- Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer (2022) (1)
- A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma. (2023) (0)
- Targeting Epigenetically Deregulated miRNA by Nutraceuticals: Focusing on Cancer Prevention and Treatment (2015) (0)
- Original Article Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through (2013) (0)
- Down regulation of androgen receptor (AR) and its target gene (PSA) expressions by B-DIM leads to sensitization of prostate cancer cells to Taxotere-induced apoptosis. (2005) (0)
- Abstract 5330: Nuclear protein export inhibitor selinexor chemotherapy combination for pancreatic cancer therapy (2022) (0)
- Abstract 1122: Novel targets for therapy resistant pancreatic neuroendocrine tumors (2021) (0)
- Epigenetic Regulations of mRNAs and miRNAs by Nutraceuticals (2013) (0)
- Correction to: Connecting the human microbiome and pancreatic cancer (2022) (0)
- Inactivation of NF-κB (2008) (0)
- Nutrition, and Cancer Indole-3-Carbinol and Prostate Cancer 1,2 (2004) (0)
- Significance of indole-3-carbinol and its metabolite in human cancers (2003) (0)
- Perspectives on the Role of Isoflavones in Prostate Cancer (2013) (0)
- Abstract 3296: The loss of miR-34a and activation of Notch-1 leads to aggressiveness of pancreatic cancer cells, which could be attenuated by CDF. (2013) (0)
- A10 A Novel Inhibitor for KRASG12C Mutant Lung Carcinoma (2020) (0)
- Abstract 2492: Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression (2018) (0)
- The Role of miRNAs in the Development of Normal Pancreas and Pancreatic Cancer, and Their Roles in Tumor Progression (2014) (0)
- Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer (2019) (0)
- Gene Expression Profiling Revealed Survivin as a Target of 3 , 3 V-Diindolylmethane-Induced Cell Growth Inhibition and Apoptosis in Breast Cancer Cells (2006) (0)
- Abstract 3328: Targeted inactivation of EZH2 by CDF inhibits pancreatic tumor growth mediated by re-expression of lost miRNAs in tumors (2012) (0)
- Prostate Cancer Bioavailability of Vascular Endothelial Growth Factor in that Regulated uPA and MMP-9 Downstream Target Genes B κ −-Diindolylmethane Is Mediated by the Nuclear Factor ′ Inhibition of Angiogenesis and Invasion by 3 , 3 (2007) (0)
- Alteration in Gene Expression and Proteomic Profiles by Soy Isoflavone (2009) (0)
- Abstract 1091: Nuclear export inhibitor KPT-8602 synergize with PARP inhibitors in castration resistant metastatic prostate cancer (2021) (0)
- Alteration in protein expression in PC-3 cells treated with SB715992 and analyzed by Western Blot an (2011) (0)
- Regulation of FOXO3a/β-catenin/GSK-3β signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. (2013) (0)
- Abstract 2383: Mir-7974: An oncogenic miRNA that perpetuates gastric cancer (2021) (0)
- Connecting the Human Microbiome and Pancreatic Cancer (2022) (0)
- Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents (2022) (0)
- Abstract 2578: Anticancer action of garcinolin vitroandin vivois mediated through inhibition of STAT-3 signaling (2012) (0)
- Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model (2022) (0)
- Contributors (2019) (0)
- DOWN-REGULATION OF PDGF-D INHIBITS CELL GROWTH AND ANGIOGENESIS THROUGH INACTIVATION OF NOTCH-1 AND NF-κB SIGNALING (2007) (0)
- Recent progress on nutraceutical research in prostate cancer (2013) (0)
- A Novel Tongue Squamous Cell Carcinoma Cell Line Escapes from Immune Recognition due to Genetic Alterations in HLA Class I Complex (2022) (0)
- Abstract 5832: Utilizing small noncoding RNAs as biomarkers for selinexor treatment in gastric cancer (2022) (0)
- A NOVEL NON-TOXIC MULTI-TARGETED APPROACH FOR PANCREATIC CANCER THERAPY (2007) (0)
- Abstract LB299: Identification of key regulators for nuclear protein export inhibitor and chemotherapy combination in pancreatic cancer using spatial genomics approach (2023) (0)
- A prospective look at genistein use in cancer prevention and treatment (2012) (0)
- Identifying the Mutational Profile of ABCB5 Upregulation in Colorectal Cancer: A Comprehensive Database Analysis (2021) (0)
- Sensitization of Cancer Cells to Cancer Therapies by Isoflavone and Its Synthetic Derivatives (2008) (0)
- Abstract 5196: CDF inhibits cell migration by inactivating cancer stem cell markers, and expression of VEGF, IL-6 and miR-21 in human pancreatic and prostate cancer cells under hypoxic condition (2012) (0)
- Inhibition of PC-3 cell proliferation was enhanced by genistein as measured by MTT assay (2011) (0)
- Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML (2022) (0)
- Abstract 2364: Pancreatic cancer stem-like cells display aggressive behavior mediated through the activation of FoxQ1 (2014) (0)
- Abstract 5589: Molecular diagnostic, prognostic and therapeutic role of mir-221 in pancreatic cancer (2014) (0)
- Pancreatic Fine Needle Aspirate miRNA miR-221 for Early Diagnosis, Prognosis and Targeted Therapy for Precision Medicine (2014) (0)
- Dual Targeting PAK4 and NAMPT As a Novel Therapeutic Approach for Aggressive Non-Hodgkin's Lymphoma (2021) (0)
- Abstract 464: Novel role of xpo1 in regulating MicroRNAs related to pancreatic ductal adenocarcinoma invasion and metastasis (2017) (0)
This paper list is powered by the following services:
